From discovery to commercialization, the life cycle of biopharmaceuticals is driven by safety, affordability, and timeliness to market. Process optimization holds the key to shortening the development ...

Recent advances have allowed transient protein expression to become a fast, flexible, and economical way to produce high-quality recombinant proteins without the time and cost associated with ...